Creative Medical Technology Holdings Inc (CELZ)
4.395
-0.16
(-3.41%)
USD |
NASDAQ |
May 03, 16:00
4.395
0.00 (0.00%)
After-Hours: 20:00
Creative Medical Technology Holdings Enterprise Value: -4.025M for May 3, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 03, 2024 | -4.025M |
| May 02, 2024 | -3.814M |
| May 01, 2024 | -3.781M |
| April 30, 2024 | -3.964M |
| April 29, 2024 | -4.038M |
| April 26, 2024 | -4.126M |
| April 25, 2024 | -4.018M |
| April 24, 2024 | -3.462M |
| April 23, 2024 | -3.448M |
| April 22, 2024 | -3.434M |
| April 19, 2024 | -3.462M |
| April 18, 2024 | -3.462M |
| April 17, 2024 | -3.211M |
| April 16, 2024 | -2.933M |
| April 15, 2024 | -2.919M |
| April 12, 2024 | -2.919M |
| April 11, 2024 | -2.573M |
| April 10, 2024 | -2.397M |
| April 09, 2024 | -2.336M |
| April 08, 2024 | -2.485M |
| April 05, 2024 | -2.499M |
| April 04, 2024 | -2.491M |
| April 03, 2024 | -2.526M |
| April 02, 2024 | -2.363M |
| April 01, 2024 | -2.444M |
| Date | Value |
|---|---|
| March 28, 2024 | -2.919M |
| March 27, 2024 | -3.001M |
| March 26, 2024 | -3.082M |
| March 25, 2024 | -2.634M |
| March 22, 2024 | -2.946M |
| March 21, 2024 | -2.721M |
| March 20, 2024 | -2.748M |
| March 19, 2024 | -2.927M |
| March 18, 2024 | -2.803M |
| March 15, 2024 | -2.625M |
| March 14, 2024 | -2.865M |
| March 13, 2024 | -1.897M |
| March 12, 2024 | -1.402M |
| March 11, 2024 | -1.127M |
| March 08, 2024 | -1.402M |
| March 07, 2024 | -1.333M |
| March 06, 2024 | -3.449M |
| March 05, 2024 | -4.316M |
| March 04, 2024 | -4.410M |
| March 01, 2024 | -4.102M |
| February 29, 2024 | -4.273M |
| February 28, 2024 | -3.957M |
| February 27, 2024 | -4.075M |
| February 26, 2024 | -4.108M |
| February 23, 2024 | -4.452M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-17.11M
Minimum
Dec 22 2022
69.86M
Maximum
Feb 10 2021
4.258M
Average
1.652M
Median
Jan 31 2020
Enterprise Value Benchmarks
| Avid Bioservices Inc | 634.42M |
| Viking Therapeutics Inc | 7.524B |
| Avinger Inc | 15.66M |
| Aptevo Therapeutics Inc | -16.38M |
| Absci Corp | 483.20M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.679M |
| Revenue (Quarterly) | 0.003M |
| Total Expenses (Quarterly) | 1.775M |
| EPS Diluted (Quarterly) | -1.21 |
| Gross Profit Margin (Quarterly) | 60.00% |
| Profit Margin (Quarterly) | -55.95K% |
| Earnings Yield | -84.41% |
| Normalized Earnings Yield | -84.41 |